Cell Medica company
Cell Medica is a cell therapy company working on new techniques to cure human diseases based upon a treatment method called cellular immunotherapy. This technique involves harnessing and enhancing the power of the human immune system to fight disease.
Based on a number of academic studies, there is strong evidence that cellular immunotherapy can be used in a safe and effective manner to treat diseases ranging from infections to cancer.
Cell Medica is both an R&D company developing new forms of cell therapies and a cell production/processing company providing clinical-grade cell formulations to hospitals for the treatment of patients.
Based on a number of academic studies, there is strong evidence that cellular immunotherapy can be used in a safe and effective manner to treat diseases ranging from infections to cancer.
Cell Medica is both an R&D company developing new forms of cell therapies and a cell production/processing company providing clinical-grade cell formulations to hospitals for the treatment of patients.
Investors
Technology:
Regenerative Medicine
Industry:
Personalized Medicine
Headquarters:
London, England, United Kingdom
Founded Date:
2005
Employees Number:
11-50
Funding Status:
Late Stage Venture
Investors Number:
7
Total Funding:
$191.8M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series C
Register and Claim Ownership